Related Experiment Video
Updated: May 17, 2025

07:05
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
22.7K
Compensatory Masseteric Bulging: A Novel Observation and Its Implications for Botulinum Neurotoxin Injection
Kyu-Ho Yi1,2, Jovian Wan3
1You and I Clinic, Seoul, Korea.
Journal of Cosmetic Dermatology
|April 7, 2025
Summary
Compensatory masseteric bulging can occur after botulinum neurotoxin injections. A new layered technique, using ultrasound, treats all muscle layers to prevent facial asymmetry.
Area of Science:
- Aesthetic Medicine
- Facial Anatomy
- Neuromodulator Therapy
Background:
- Compensatory masseteric bulging is a novel complication from botulinum neurotoxin (BoNT) injections targeting the lower masseter.
- This hypertrophy of upper masseteric layers occurs due to compensatory mechanisms for weakened lower regions, leading to facial asymmetry.
- Conventional injection methods often neglect the masseter's three-layered anatomy (superficial, middle, deep), increasing the risk of asymmetry.
Purpose of the Study:
- To introduce a novel retrograde, layered injection technique for BoNT administration in the masseter muscle.
- To prevent compensatory masseteric bulging and improve facial symmetry.
- To highlight the importance of anatomical precision and tailored dosing in masseter hypertrophy management.
Main Methods:
- A retrograde, layered injection approach is proposed, ensuring even distribution of BoNT across all masseteric layers.
- Ultrasound guidance is utilized for precise toxin delivery, targeting specific muscle layers and avoiding adjacent structures.
- Personalized dosing strategies are implemented, considering individual muscle thickness, activity, and prior treatment history to prevent over-atrophy.
Main Results:
- A case study of a 34-year-old female demonstrated upper masseter hypertrophy (12 mm) after sequential lower masseter BoNT treatments.
- Ultrasound imaging confirmed hypertrophy in the upper layer and atrophy in the lower layer.
- Treatment with 50 units of LetibotulinumtoxinA via the layered technique reduced upper masseter thickness to 8 mm, successfully restoring facial symmetry.
Conclusions:
- Compensatory bulging necessitates a comprehensive treatment approach that addresses the entire masseter muscle.
- Layered injections, enhanced by ultrasound guidance and personalized dosing, effectively mitigate the risk of facial asymmetry.
- Clinicians should integrate detailed anatomical knowledge and advanced imaging for optimal outcomes in managing masseter hypertrophy.
Related Concept Videos
Skeletal Muscle Relaxants: Therapeutic Uses
444
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
444
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
632
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
632
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
371
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
371
Skeletal Muscle Relaxants: Adverse Effects
322
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
322
Muscles for Facial Expressions
1.7K
The craniofacial muscles are a collection of approximately 20 thin skeletal muscles situated beneath the skin of the face and scalp. These muscles, primarily responsible for the vast array of human facial expressions, originate from the bones or fibrous structures of the skull and extend outwards to connect with the skin. While most skeletal muscles in the body are enveloped in thick fascia, facial muscles generally have a more delicate fascial covering, with the buccinator muscle being a...
1.7K

